Results 171 to 180 of about 117,976 (202)

Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release

American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
Glucagon-like peptide-2 (GLP-2) influences different aspects of the gastrointestinal function, including epithelial growth, digestion, absorption, motility, and blood flow. Intraluminal pressure from isolated mouse stomach was recorded to investigate whether GLP-2 affects gastric tone and to analyze its mechanism of action.
AMATO, Antonella, BALDASSANO, Sara, SERIO, Rosa Maria, MULE', Flavia   +3 more
openaire   +3 more sources

Glucagon‐like peptide‐2 inhibits antral emptying in man, but is not as potent as glucagon‐like peptide‐1

Scandinavian Journal of Gastroenterology, 2004
GLP-1 (glucagon-like peptide-1) and GLP-2 (glucagon-like peptide-2) are released in equimolar amounts in response to meal ingestion. GLP-1 inhibits gastric emptying and reduces postprandial gastric and exocrine pancreatic secretion and may play a physiological regulatory role in controlling appetite and energy intake in humans.
Nagell, C F, Wettergren, A, Pedersen, J F, Mortensen, D, Holst, Jens Juul   +4 more
openaire   +2 more sources

Glucagon-like peptide-2: divergent signaling pathways.

The Journal of surgical research, 2004
Glucagon-like peptide 2 (GLP-2) is an endogenous hormone with potent and specific intestinotrophic activity in vivo and in vitro. The aim of this study was to define the initial signal transduction mechanisms mediating the proliferative actions of GLP-2 on intestinal epithelial cells.The proliferative actions of GLP-2 on the human Caco-2 cell line were
Flavio G, Rocha, K Robert, Shen, Jasleen, Jasleen, Ali, Tavakkolizadeh, Michael J, Zinner, Edward E, Whang, Stanley W, Ashley   +6 more
openaire   +1 more source

Glucagon-like peptide-2

2021
openaire   +1 more source

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease

Endocrine Reviews, 2023
Daniel J Drucker
exaly  

Glucagon Like Peptide 2 (GLP-2)

2018
Georgios K. Dimitriadis, Alexander D. Miras   +1 more
openaire   +1 more source

Glucagon-like peptide-2: Divergent signaling pathways1

Journal of Surgical Research, 2004
Flavio G. Rocha, K. Robert Shen, Jasleen Jasleen, Ali Tavakkolizadeh, Michael J. Zinner, Edward E. Whang, Stanley W. Ashley   +6 more
openaire   +1 more source

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

New England Journal of Medicine, 1992
Bo Ahrén
exaly  

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Lancet, The, 2002
Sten Madsbad, Jens J Holst Dmsci
exaly  

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

Circulation, 2013
Ilya M Mukovozov, Ren-Ke Li, Filio Billia   +2 more
exaly